Вроджена гіперплазія надниркових залоз внаслідок дефіциту 21-гідроксилази Клінічні практичні настанови Ендокринологічного Товариства. Частина 3
Ключові слова:
-Анотація
-Посилання
Lesma A, Bocciardi A, Corti S, Chiumello G, Rigatti P, Montorsi F. Sexual function in adult life following Passerini-Glazel feminizing genitoplasty in patients with congenital adrenal hyperplasia. J Urol. 2014;191(1):206-211.
Houben CH, Tsui SY, Mou JW, Chan KW, Tam YH, Lee KH. Reconstructive surgery for females with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review from the Prince of Wales Hospital. Hong Kong Med J. 2014;20(6):481-485.
Yankovic F, Cherian A, Steven L, Mathur A, Cuckow P. Current practice in feminizing surgery for congenital adrenal hyperplasia; a specialist survey. J Pediatr Urol. 2013;9(6 Pt B):1103-1107.
van der Zwan YG, Janssen EH, Callens N, Wolffenbuttel KP, Cohen-Kettenis PT, van den Berg M, Drop SL, Dessens AB, Beerendonk C; Dutch Study Group on DSD. Severity of virilization is associated with cosmetic appearance and sexual function in women with congenital adrenal hyperplasia: a cross-sectional study. J Sex Med. 2013;10(3):866-875.
Binet A, Lardy H, Geslin D, Francois-Fiquet C, Poli-Merol ML. Should we questionearly feminizing genitoplasty for patients with congenital adrenal hyperplasia and XX karyotype? J Pediatr Surg. 2016;51(3):465-468.
Rink RC. Genitoplasty/vaginoplasty. Adv Exp Med Biol. 2011; 707:51-54.
Crouch NS, Liao LM, Woodhouse CR, Conway GS, Creighton SM. Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia. J Urol. 2008; 179(2):634-638.
Nordenskj¨old A, Holmdahl G, Fris´en L, Falhammar H, Filipsson H, Thor´en M, Janson PO, Hagenfeldt K. Type of mutation and surgical procedure affect long-term quality of life for women with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2008; 93(2):380-386.
Marei MM, Fares AE, Musa N, Abdelsattar AH, Sharaf A, Hassan MM, Elkotby M, Eltagy G, Hafez M, Elbarbary MM. Timing and outcome concerns regarding feminizing genitoplasty from the perspective of Egyptian families of girls with virilized external genitalia. Horm Res Paediatr. 2016;85(1):49-57.
Martínez-Criado Y, Gómez AL, Fernández-Hurtado MA, Barrero R, García-Merino F. [Role of pediatric urologist in the treatment of congenital adrenal hyperplasia: a study of satisfaction and psychosocial aspects]. Cir Pediatr. 2013;26(2):75-80.
Sturm RM, Durbin-Johnson B, Kurzrock EA. Congenital adrenal hyperplasia: current surgical management at academic medical centers in the United States. J Urol. 2015;193(5 Suppl): 1796-1801.
Roth JD, Casey JT, Whittam BM, Bennett WEJr, Szymanski KM, Cain MP, Rink RC. Characteristics of female genital restoration surgery for congenital adrenal hyperplasia using a large-scale administrative database. Urology. 2018;115:162-167.
Sun LS, Li G, Miller TL, Salorio C, Byrne MW, Bellinger DC, Ing C, Park R, Radcliffe J, Hays SR, DiMaggio CJ, Cooper TJ, Rauh V, Maxwell LG, Youn A, McGowan FX. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA. 2016; 315(21):2312-2320.
Backeljauw B, Holland SK, Altaye M, Loepke AW. Cognitionand brain structure following early childhood surgery with anesthesia. Pediatrics. 2015;136(1):e1-e12.
Merke DP, Poppas DP. Management of adolescents with congenital adrenal hyperplasia. Lancet Diabetes Endocrinol. 2013; 1(4):341-352.
Szymanski KM, Whittam B, Kaefer M, Frady H, Casey JT, Tran VT, Cain MP, Rink RC. Parental decisional regret and views about optimal timing of female genital restoration surgery in congenital adrenal hyperplasia. J Pediatr Urol. 2018;14(2):156.e1-156.e7.
Auchus RJ, Witchel SF, Leight KR, Aisenberg J, Azziz R, Bachega TA, Baker LA, Baratz AB, Baskin LS, Berenbaum SA, Breault DT, Cerame BI, Conway GS, Eugster EA, Fracassa S, Gearhart JP, Geffner ME, Harris KB, Hurwitz RS, Katz AL, Kalro BN, Lee PA, Alger Lin G, Loechner KJ, Marshall I, Merke DP, Migeon CJ, Miller WL, Nenadovich TL, Oberfield SE, Pass KA, Poppas DP, Lloyd-PuryearMA, QuigleyCA, Riepe FG, Rink RC, Rivkees SA, Sandberg DE, Schaeffer TL, Schlussel RN, Schneck FX, Seely EW, Snyder D, Speiser PW, Therrell BL, Vanryzin C, Vogiatzi MG, Wajnrajch MP, White PC, Zuckerman AE. Guidelines for the development of comprehensive care centers for congenital adrenal hyperplasia: guidance from the CARES Foundation initiative. Int J Pediatr Endocrinol. 2010;2010(1):275213.
Peña A. Total urogenital mobilization-an easier way to repair cloacas. J Pediatr Surg. 1997;32(2):263-267.
Kalfa N, Liu B, Cao M, Vilella M, Hsieh M, Baskin LS. 3-Dimensional neuroanatomy of the human fetal pelvis: anatomical support for partial urogenital mobilization in the treatment of urogenital sinus. J Urol. 2008;180(4 Suppl):1709-1714.
Poppas DP. Clitoroplasty in congenital adrenal hyperplasia: description of technique. Adv Exp Med Biol. 2011;707:49-50.
Peña A. The surgical management of persistent cloaca: results in 54 patients treated with a posterior sagittal approach. J Pediatr Surg. 1989;24(6):590-598.
Rink RC, Adams MC. Feminizing genitoplasty: state of the art. World J Urol. 1998;16(3):212-218.
Rink RC, Herndon CD, Cain MP, Kaefer M, Dussinger AM, King SJ, Casale AJ. Upper and lower urinary tract outcome after surgical repair of cloacal malformations: a three-decade experience. BJU Int. 2005;96(1):131-134.
Rink RC, Metcalfe PD, Cain MP, Meldrum KK, Kaefer MA, Casale AJ. Use of the mobilized sinus with total urogenital mobilization. J Urol. 2006;176(5):2205-2211.
Stites J, Bernabe KJ, Galan D, Felsen D, Poppas DP. Urinary continence outcomes following vaginoplasty in patients with congenital adrenal hyperplasia. J Pediatr Urol. 2017;13(1):38. e1-38.e7.
Podesta M, Urcullo J. Perineal mobilization of the common urogenital sinus for surgical correction of high urethrovaginal confluence in patients with intersex disorders. J Pediatr Urol. 2008;4(5):352-358.
Ludwikowski BM, Gonz´alez R. The surgical correction of urogenital sinus in patients with DSD: 15 years after description of total urogenital mobilization in children. Front Pediatr. 2013;1: 41.
Salle JL, Lorenzo AJ, Jesus LE, Leslie B, AlSaid A, Macedo FN, Jayanthi VR, de Castro R. Surgical treatment of high urogenital sinuses using the anterior sagittal transrectal approach: a useful strategy to optimize exposure and outcomes. JUrol.2012;187(3): 1024-1031.
Baskin LS, Erol A, Li YW, Liu WH, Kurzrock E, Cunha GR. Anatomical studies of the human clitoris. J Urol. 1999;162(3 Pt 2):1015-1020.
Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, Darzy K, Merke DP, Arlt W, Ross RJ. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94(5):1548-1554.
Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, HellmanL. Twenty-fourhourpatternoftheepisodicsecretion of cortisol in normal subjects. J Clin Endocrinol Metab. 1971; 33(1):14-22.
Bryan SM, Honour JW, Hindmarsh PC. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. J Clin Endocrinol Metab. 2009;94(9):3477-3480.
Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-PriceJ, TuckerGT, RossRJ. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 2006;65(1):45-50.
Nella AA, Mallappa A, Perritt AF, Gounden V, Kumar P, Sinaii N, Daley LA, Ling A, Liu CY, Soldin SJ, Merke DP. A phase 2 study of continuous subcutaneous hydrocortisone infusion in adults with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2016;101(12):4690-4698.
Verma S, Vanryzin C, Sinaii N, Kim MS, Nieman LK, Ravindran S, Calis KA, Arlt W, Ross RJ, Merke DP. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 2010;72(4):441-447.
Mallappa A, Sinaii N, Kumar P, Whitaker MJ, Daley LA, Digweed D, Eckland DJ, Van RyzinC, Nieman LK, Arlt W, Ross RJ, MerkeDP. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2015;100(3):1137-1145.
Neumann U, Whitaker MJ, Wiegand S, Krude H, Porter J, Davies M, Digweed D, Voet B, Ross RJ, Blankenstein O. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. Clin Endocrinol (Oxf). 2018;88(1): 21-29.
Laue L, Merke DP, Jones JV, Barnes KM, Hill S, Cutler GB Jr. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1996;81(10):3535-3539.
Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB Jr. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2000;85(3):1114-1120.
Garrido M, Peng HM, Yoshimoto FK, Upadhyay SK, Bratoeff E, Auchus RJ. A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone. J Steroid Biochem Mol Biol. 2014;143:1-10.
de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fl´echon A, Saleh M, ScholzM, Efstathiou E, Zivi A, BianchiniD, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI; COU-AA301 Investigators. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011;364(21): 1995-2005.
Ryan CJ, Molina A, Griffin T. Abiraterone in metastatic prostate cancer. N Engl J Med. 2013;368(15):1458-1459.
Auchus RJ, Buschur EO, Chang AY, Hammer GD, Ramm C, Madrigal D, Wang G, Gonzalez M, Xu XS, Smit JW, Jiao J, Yu MK. Abiraterone acetate to lower androgens in women with classic21-hydroxylase deficiency. J Clin Endocrinol Metab.2014; 99(8):2763-2770.
New MI, Gertner JM, Speiser PW, Del Balzo P. Growth and final height in classical and nonclassical 21-hydroxylase deficiency. J Endocrinol Invest. 1989;12(8 Suppl 3):91-95.
Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height. Eur J Endocrinol. 1997;136(2):188-195.
Quintos JBQ, Vogiatzi MG, Harbison MD, New MI. Growth hormone therapy alone or in combination with gonadotropin releasing ghormone analog therapy to improve the height deficitin children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2001;86(4):1511-1517.
Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, Tansil S, New MI. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2005;90(6):3318-3325.
Dacou-Voutetakis C, Karidis N. Congenital adrenal hyperplasia complicated by central precocious puberty: treatment with LHRHagonist analogue. Ann N Y Acad Sci. 1993;687:250-254.
Turcu AF, Spencer-Segal JL, Farber RH, Luo R, Grigoriadis DE, Ramm CA, Madriga lD, Muth T, O’Brien CF, Auchus RJ. Singledose study of a corticotropin-releasing factor receptor-1 antagonist in women with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2016;101(3):1174-1180.
Bry-Gauillard H, Cartes A, Young J. Mitotane for 21-hydroxylase deficiency in an infertile man. N Engl J Med. 2014;371(21):2042-2044.
Cheng Y, Kerppola RE, Kerppola TK. ATR-101 disrupts mitochondrial functions in adrenocortical carcinoma cells and in vivo. Endocr Relat Cancer. 2016;23(4):1-19.
LaPensee CR, Mann JE, Rainey WE, Crudo V, Hunt SW III, Hammer GD. ATR-101, a selective and potent inhibitor of acylCoA acyltransferase 1, induces apoptosis in H295R adrenocortical cells and in the adrenal cortex of dogs. Endocrinology. 2016;157(5):1775-1788.
Sbiera S, Leich E, Liebisch G, Sbiera I, Schirbel A, Wiemer L, Matysik S, Eckhardt C, Gardill F, Gehl A, Kendl S, Weigand I, Bala M, Ronchi CL, Deutschbein T, Schmitz G, Rosenwald A, AllolioB, FassnachtM, KroissM. Mitotane inhibits sterol-O-acyl transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells. Endocrinology. 2015;156(11):3895-3908.
Van Wyk JJ, Ritzen EM. The role of bilateral adrenalectomy in the treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2003;88(7):2993-2998.
Ogilvie CM, Rumsby G, Kurzawinski T, Conway GS. Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit’s experience. Eur J Endocrinol. 2006;154(3):405-408.
Tiosano D, Vlodavsky E, Filmar S, Weiner Z, Goldsher D, BarShalom R. Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy. Horm Res Paediatr. 2010;74(3): 223-228.
Crocker MK, Barak S, Millo CM, Beall SA, Niyyati M, Chang R, Avila NA, Van Ryzin C, Segars J, Quezado M, Merke DP. Use of PET/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2012;97(11):E2084-E2089.
Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med. 2000;343(19):1362-1368.
Riepe FG, Krone N, Krüger SN, Sweep FC, Lenders JW, Dötsch J, Mönig H, Sippell WG, Partsch CJ. Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21hydroxylase deficiency. Exp Clin Endocrinol Diabetes. 2006; 114(3):105-110.
Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Hiroi M, Eisenhofer G, Yanovski JA, Chrousos GP, Merke DP. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. J Clin Endocrinol Metab. 2004;89(2):591-597.
Green-Golan L, Yates C, Drinkard B, VanRyzin C, Eisenhofer G, Weise M, Merke DP. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glycemic control during prolonged moderate-intensity exercise. J Clin Endocrinol Metab. 2007;92(8):3019-3024.
Kim MS, Ryabets-Lienhard A, Bali B, Lane CJ, Park AH, Hall S, Geffner ME. Decreased adrenomedullary function in infants with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2014;99(8):E1597-E1601.
TajimaT, Okada T, Ma XM, Ramsey W, Bornstein S, Aguilera G. Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochrome P450 21-hydroxylase into the adrenalglandof21-hydroxylase-deficient mice. Gene Ther.1999; 6(11):1898-1903.
Ruiz-Babot G, Hadjidemetriou I, King PJ, Guasti L. New directions for the treatment of adrenal insufficiency. Front Endocrinol (Lausanne). 2015;6:70.
Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha SJ, Taylor DR, Ghataore L, Taylor NF, Schubert U, Ziegler CG, Storr HL, Druce MR, Gevers EF, Drake WM, Srirangalingam U, Conway GS, King PJ, Metherell LA, Bornstein SR, Guasti L. Modeling congenital adrenal hyperplasia and testing interventions for adrenal insufficiency using donor-specific reprogrammed cells. Cell Reports. 2018;22(5):1236-1249.
Meyer-Bahlburg HFL. Psychoendocrinology of congenital adrenal hyperplasia. In: New MI, Lekarev O, Parsa A, Yuen TT, O’Malley BW, Hammer GD, eds. Genetic Steroid Disorders. San Diego, CA: Academic Press; 2014:285-300.
Al-Maghribi H. Congenital adrenal hyperplasia: problems with developmental anomalies of the external genitalia and sex assignment. Saudi J Kidney Dis Transpl. 2007;18(3):405-413.
Chowdhury TK, Laila K, Hutson JM, Banu T. Male gender identity in children with 46,XX DSD with congenital adrenal hyperplasiaafterdelayedpresentationinmid-childhood.JPediatr Surg. 2015;50(12):2060-2062.
Meyer-Bahlburg HFL. Gender monitoring and gender reassignment of children and adolescents with a somatic disorder of sex development. Child Adolesc Psychiatr Clin N Am. 2011;20(4): 639-649.
LeePA, HoukCP, HusmannDA. Should male gender assignment be considered in the markedly virilized patient With 46,XX and congenital adrenal hyperplasia? J Urol. 2010;184(4 Suppl): 1786-1792.
Meyer-Bahlburg HFL, Dolezal C, Baker SW, Ehrhardt AA, New MI. Gender development in women with congenital adrenal hyperplasia as a function of disorder severity. Arch Sex Behav. 2006;35(6):667-684.
HinesM, ConstantinescuM, SpencerD. Early androgen exposure and human gender development. Biol Sex Differ. 2015;6(1):3.
Meyer-Bahlburg HFL, Baratz Dalke K, Berenbaum SA, CohenKettenis PT, Hines M, Schober JM. Gender assignment, reassignment and outcome in disorder sof sex development: update of the 2005 consensus conference. Horm Res Paediatr. 2016;85(2): 112-118.
Hines M, Pasterski V, Spencer D, Neufeld S, Patalay P, Hindmarsh PC, Hughes IA, Acerini CL. Prenatal androgen exposure alters girls’ responses to information indicating gender appropriate behaviour. Philos Trans R Soc Lond B Biol Sci.2016; 371(1688):20150125.
Endendijk JJ, Beltz AM, McHale SM, Bryk K, Berenbaum SA. Linking prenatal androgens to gender-related attitudes, identity, and activities: evidence from girls with congenital adrenal hyperplasia. Arch Sex Behav. 2016;45(7):1807-1815.
Pasterski V, Zucker KJ, Hindmarsh PC, Hughes IA, Acerini C, Spencer D, Neufeld S, Hines M. Increased cross-gender identification in dependent of gender role behavior in girlswith congenital adrenal hyperplasia: results from a standardized assessment of 4 to 11-year-old children. Arch Sex Behav.2015;44(5):1363-1375.
Dessens AB, Slijper FM, Drop SL. Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav. 2005;34(4):389-397.
Meyer-Bahlburg HFL. Gender assignment and reassignment in intersexuality: controversies, data, and guidelines for research. Adv Exp Med Biol. 2002;511:199-223.
Liao L-M, Wood D, Creighton SM. Parental choice on normalising cosmetic genital surgery. BMJ. 2015;351:h5124.
Tamar-Mattis A. Patient advocate responds to DSD surgery debate. J Pediatr Urol. 2014;10(4):788-789.
SytsmaSE. Ethicsand Intersex. Dordrecht, Netherlands: Springer Netherlands, 2006.
Feder EK, Dreger A. Still ignoring human rights in intersex care. J Pediatr Urol. 2016;12(6):436-437.
Dreger AD. Intersex and human rights: the long view. In: Sytsma SE, ed. Ethics and Intersex. Dordrecht, Netherlands: Springer; 2006:73-86.
Diamond M, Beh H.G. The right to be wrong: sex and gender decisions. In: Sytsma SE, ed. Ethics and Intersex. Dordrecht, Netherlands: Springer; 2006:103-114.
Creighton SM. Adult outcomes of feminizing surgery. In: Sytsma SE, ed. Ethics and Intersex. Dordrecht, Netherlands: Springer; 2006:207-214.
Diamond M, Sigmundson HK. Management of intersexuality. Guidelines for dealing with persons with ambiguous genitalia. Arch Pediatr Adolesc Med. 1997;151(10):1046-1050.
Wisniewski AB, Migeon CJ, Malouf MA, Gearhart JP. Psychosexual outcome in women affected by congenital adrenal hyperplasiadueto21-hydroxylase deficiency. J Urol.2004;171(6Pt 1):2497-2501.
Fagerholm R, Santtila P, Miettinen PJ, Mattila A, Rintala R, Taskinen S. Sexual function and attitudes toward surgery after feminizing genitoplasty. J Urol. 2011;185(5):1900-1904.
Zhang H, Pan J, Ji H, Wang Y, Shen W, Liu L, Lu G, Zhou Z. Long-term evaluation of patients undergoing genitoplasty due to disorders of sex development: results from a 14-year follow-up. Sci World J. 2013;2013:298015.
Dayner JE, Lee PA, Houk CP. Medical treatment of intersex: parental perspectives. J Urol. 2004;172(4 pt 2):1762-1765.
Lundberg T, Lindstr¨om A, Roen K, Hegarty P. From knowing nothing to knowing what, how and now: parents’ experiences of caring for their children with congenital adrenal hyperplasia. J Pediatr Psychol. 2017;42(5):520-529.
Reisch N, Hahner S, Bleicken B, Flade L, Pedrosa Gil F, Loeffler M, Ventz M, Hinz A, Beuschlein F, Allolio B, Reincke M, Quinkler M. Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin Endocrinol (Oxf). 2011;74(2):166-173.
Frisén L, Nordenström A, Falhammar H, Filipsson H, Holmdahl G, JansonPO, ThorénM, HagenfeldtK, Möller A, Nordenskjöld A. Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J Clin Endocrinol Metab. 2009;94(9):3432-3439.
Kuhnle U, Bullinger M. Outcome of congenital adrenal hyperplasia. Pediatr Surg Int. 1997;12(7):511-515.
Kuhnle U, Bullinger M, Schwarz HP. The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients life. Eur J Pediatr. 1995;154(9): 708-716.
SanchesSA, WiegersTA, OttenBJ, Claahsen-vander GrintenHL. Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population. Int J Pediatr Endocrinol. 2012;2012(1):2.
Johannsen TH, Ripa CPL, Mortensen EL, Main KM. Quality of life in 70 women with disorders of sex development. Eur J Endocrinol. 2006;155(6):877-885.
GilbanDL, AlvesJunior PA, BeserraIC. Health related qualityof life of children and adolescents with congenital adrenal hyperplasia in Brazil. Health Qual Life Outcomes. 2014;12(1):107.
Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg AL, Wedell A, Norrby C, Nordenskj¨old A, Fris´en L, Nordenstr¨om A. Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden. J Clin Endocrinol Metab. 2014;99(4): 1425-1432.
Han TS, Krone N, Willis DS, Conway GS, Hahner S, Rees DA, Stimson RH, Walker BR, Arlt W, Ross RJ; United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE). Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE). Eur J Endocrinol. 2013; 168(6):887-893.
Engberg H, Butwicka A, Nordenstr¨om A, Hirschberg AL, Falhammar H, Lichtenstein P, Nordenskjöld A, Frisén L, Landén M. Congenital adrenal hyperplasia and risk for psychiatric disorders in girls and women born between 1915 and 2010: a total population study. Psychoneuroendocrinology. 2015;60:195-205.
Falhammar H, Butwicka A, Land´en M, Lichtenstein P, Nordenskj¨old A, Nordenstr¨om A, Fris´en L. Increased psychiatric morbidity in men with congenital adrenal hyperplasia due to 21hydroxylase deficiency. J Clin Endocrinol Metab. 2014;99(3): E554-E560.
Clayton PE, Miller WL, Oberfield SE, Ritz´en EM, Sippell WG, Speiser; ESPE/LWPES CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm Res. 2002;58(4):188-195.
Cohen-Kettenis P, Pfafflin S. Transgenderism and Intersexuality in Childhood and Adolescence: Making Choices.Thous and Oaks, CA: Sage Publications; 2003.
Consortium on the Management of Disorders of Sex Development. Handbook for Parents. Available at: www.dsdguidelines. org. Accessed 14 September 2018.
Consortium on the Management of Disorders of Sex Development. Clinical Guidelines for the Management of Disorders of Sexual Differentiation in Childhood. Available at: www.dsdguidelines. org/. Accessed 14 September 2018.
Hughes IA, Houk C, Ahmed SF, Lee PA; Lawson Wilkins Pediatric Endocrine Society/European Society for Paediatric Endocrinology Consensus Group. Consensus statement on management of intersex disorders. J Pediatr Urol. 2006;2(3):148-162.
Brain CE, Creighton SM, Mushtaq I, Carmichael PA, Barnicoat A, Honour JW, Larcher V, Achermann JC. Holistic management of DSD. Best Pract Res Clin Endocrinol Metab. 2010;24(2):335-354.
Martin CL, Ruble DN. Patterns of gender development. Annu Rev Psychol. 2010;61(1):353-381.
Blakemore JE, Berenbaum SA, Liben LS. Gender Development. New York, NY: Psychology Press/Taylor&FrancisGroup;2009.
Meyer-Bahlburg HFL, Khuri J, Reyes-Portillo J, New MI. Stigma in medical settings as reported retrospectively by women with congenital adrenal hyperplasia (CAH) for their childhood and adolescence. J Pediatr Psychol. 2017;42(5):496-503.
Meyer-Bahlburg HFL, Dolezal C, Baker SW, New MI. Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav. 2008;37(1):85-99.
Meyer-Bahlburg HFL. Treatment guidelines for children with disorders of sex development. Neuropsychiatr Enfance Adolesc. 2008;56(6):345-349.
MoneyJ. Sex Errors of the Body and Related Syndromes: A Guide to Counseling Children, Adolescents, and Their Families. 2nd ed. Baltimore, MD: Paul H. Brookes Publishing; 1994.
Hsu C, Rivkees SA. Congenital Adrenal Hyperplasia: A Parents’ Guide. Bloomington, IN: Author House; 2005.
Sandberg DE, Gardner M, Callens N, Mazur T; DSD-TRN Psychosocial Workgroup, the DSD-TRN Advocacy Advisory Network, and Accord Alliance. Interdisciplinary care in disorders/ differences of sex development (DSD): the psychosocial component of the DSD-Translational Research Network. Am J Med Genet C Semin Med Genet. 2017;175(2):279-292.
Nordenstr¨om A, Thyen U. Improving the communication of healthcare professionals with affected children and adolescents. Endocr Dev. 2014;27:113-127.
McCauley E. Challenges in educating patients and parents about differences in sex development. Am J Med Genet C Semin Med Genet. 2017;175(2):293-299.
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H, Jaeschke R, Rind D, Meerpohl J, Dahm P, Sch¨unemann HJ. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso Coello P, Sch¨unemann HJ; GRADE Working Group.GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
Guyatt GH, Sch¨unemann HJ, Djulbegovic B, Akl EA. Guideline panels should not GRADE good practice statements. J Clin Epidemiol. 2015;68(5):597-600.
